Effect of Subanesthetic Dose of Esketamine on Perioperative Neurocognitive Disorders in Elderly Undergoing Gastrointestinal Surgery: A Randomized Controlled Trial
- PMID: 36974331
- PMCID: PMC10039635
- DOI: 10.2147/DDDT.S401161
Effect of Subanesthetic Dose of Esketamine on Perioperative Neurocognitive Disorders in Elderly Undergoing Gastrointestinal Surgery: A Randomized Controlled Trial
Abstract
Background: Perioperative neurocognitive disorders (PND), including delayed neurocognitive recovery (dNCR) and postoperative cognitive dysfunction (POCD), are common postoperative complications in elderly patients and adversely affect their prognosis. The study was designed to explore the effects of esketamine on postoperative cognitive function in elderly patients who underwent gastrointestinal surgery under general anesthesia and its potential mechanism.
Methods: Eighty-four patients aged 65 and above undergoing gastrointestinal surgery were randomly divided into 2 groups: the esketamine group (group S) and the control group (group C). Group S received intravenous sub-anesthetic doses of esketamine (0.15 mg/kg) 5 minutes before the initiation of surgery, while group C received the same volume of saline. A battery of neuropsychological tests was used to assess cognitive function before surgery, 7 days, and 3 months after surgery. The primary outcome was the incidence of dNCR at 7 days postoperatively and POCD at 3 months postoperatively in both groups. The secondary outcome measures included changes in the levels of serum interleukin-6 (IL-6) and calcium-binding protein β (S100β) before and 1 day after surgery.
Results: The incidence of dNCR in group S was lower than that of group C (18.15% vs 38.24% P=0.033). Contrarily, there was no difference in both groups regarding POCD 3 months postoperatively (6.06% vs 14.37% P=0.247). Plasma IL-6 and S100β levels were significantly elevated in both groups on postoperative day 1 (p<0.05), but esketamine pretreatment reduced these levels to some extent compared with group C (p<0.05).
Conclusion: Sub-anesthetic doses of esketamine might reduce the incidence of dNCR and improve early postoperative cognitive function in elderly patients undergoing gastrointestinal surgery, which might be related to the anti-neuroinflammation effects of esketamine.
Keywords: elderly; esketamine; gastrointestinal surgery; neuroinflammatory; perioperative neurocognitive disorders.
© 2023 Han et al.
Conflict of interest statement
The authors declare that they have no competing interests in this work.
Figures
Similar articles
-
Esketamine and neurocognitive disorders in adult surgical patients: a meta-analysis.BMC Anesthesiol. 2024 Dec 5;24(1):448. doi: 10.1186/s12871-024-02803-3. BMC Anesthesiol. 2024. PMID: 39639216 Free PMC article.
-
Effects of Esketamine Combined with Dexmedetomidine on Early Postoperative Cognitive Function in Elderly Patients Undergoing Lumbar Spinal Surgery: A Double-Blind Randomized Controlled Clinical Trial.Drug Des Devel Ther. 2024 Nov 27;18:5461-5472. doi: 10.2147/DDDT.S481173. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39624770 Free PMC article. Clinical Trial.
-
Effect of small dose esketamine on perioperative neurocognitive disorder and postoperative depressive symptoms in elderly patients undergoing major elective noncardiac surgery for malignant tumors: A randomized clinical trial.Medicine (Baltimore). 2024 Oct 18;103(42):e40028. doi: 10.1097/MD.0000000000040028. Medicine (Baltimore). 2024. PMID: 39432604 Free PMC article. Clinical Trial.
-
The Effect of Low-Dose Esketamine on Postoperative Neurocognitive Dysfunction in Elderly Patients Undergoing General Anesthesia for Gastrointestinal Tumors: A Randomized Controlled Trial.Drug Des Devel Ther. 2023 Jun 29;17:1945-1957. doi: 10.2147/DDDT.S406568. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37408867 Free PMC article. Clinical Trial.
-
Impact of perioperative esketamine on the perioperative neurocognitive dysfunction: a systematic review and meta-analysis of randomised controlled studies.BMJ Open. 2025 May 21;15(5):e095695. doi: 10.1136/bmjopen-2024-095695. BMJ Open. 2025. PMID: 40398929 Free PMC article.
Cited by
-
Intravenous esketamine as a detumescence agent for intraoperative penile erection during urological surgeries: a retrospective clinical analysis.BMC Anesthesiol. 2025 May 8;25(1):233. doi: 10.1186/s12871-025-03068-0. BMC Anesthesiol. 2025. PMID: 40340794 Free PMC article.
-
The influence of low-dose s-ketamine on postoperative delirium and cognitive function in older adults undergoing thoracic surgery.J Cardiothorac Surg. 2024 Jun 7;19(1):324. doi: 10.1186/s13019-024-02811-x. J Cardiothorac Surg. 2024. PMID: 38849859 Free PMC article.
-
Effect of Esketamine on Cognitive Recovery After Propofol Sedation for Outpatient Colonoscopy: A Randomized Clinical Trial.Drug Des Devel Ther. 2025 Jan 21;19:425-437. doi: 10.2147/DDDT.S503129. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 39867863 Free PMC article. Clinical Trial.
-
The effects of esketamine on postoperative delirium in older patients with fragile brain function during the non-acute phase following lung cancer surgery: a randomized controlled trial.BMC Geriatr. 2025 Aug 9;25(1):608. doi: 10.1186/s12877-025-06268-y. BMC Geriatr. 2025. PMID: 40783518 Free PMC article. Clinical Trial.
-
Esketamine and neurocognitive disorders in adult surgical patients: a meta-analysis.BMC Anesthesiol. 2024 Dec 5;24(1):448. doi: 10.1186/s12871-024-02803-3. BMC Anesthesiol. 2024. PMID: 39639216 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources